Biotech Stock News (SRPT)(SPHS)

Sarepta Therapeutics (NASDAQ:SRPT) On Monday June 6, 2016 shares of Sarepta Therapeutics were up more than 31% in after-hours trade after the company announced that the FDA had requested for additional data for the Eteplirsen decision. The market clearly viewed the fact that the FDA needed more data as a positive. Which is why shares … Read more

Biotech Stock News (AVXL) (BIIB) (LLY) (SPHS) (KBIO)

Anavex Life Sciences (NASDAQ:AVXL) On November 9, 2015 Anavex reported positive phase 2a results for the trial treating patients with Alzheimer’s. This trial tested two clinical endpoints. The first clinical endpoint was testing for safety as it is customary with all phase 2a trials. The second endpoint was looking for preliminary clinical efficacy. In terms … Read more